Patients receiving fesoterodine 4 mg had significantly greater improvements in UUI episodes , urgency episodes , and micturitions ; significantly higher diary-dry rates ; and significantly greater improvement in PPBC scores and OAB-q scores than patients receiving placebo ( all P < 0.05 ) .